Literature DB >> 22431534

Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors.

Pamela P Goodell1, Alyssa M Krasinskas, Jon M Davison, Douglas J Hartman.   

Abstract

Assessment of proliferative activity is required for grading well-differentiated pancreatic neuroendocrine tumors. However, a standardized method for obtaining the Ki-67 proliferative index is lacking. This study compared proliferative activity obtained by 3 methods: single-field hot spot (Ki-67 HS) and 10 consecutive field average (Ki-67 CFA) using the Ventana image analysis system (Ventana Medical Systems, Tucson, AZ) and mitotic index (MI). These methods resulted in discrepant grades in 30 (67%) of our 45 cases. With the current Ki-67 cutoff of more than 2% for intermediate-grade tumors, MI, CFA, and HS resulted in specificities of 91%, 94%, and 31%, respectively, for detecting metastasis, with positive predictive values (PPVs) of 25%, 67%, and 31%, respectively. At a higher Ki-67 cutoff of 7.5%, HS analysis resulted in a specificity of 94% and PPV of 71% for predicting metastasis. While single-field HS analysis may be practical and reliable at a higher cutoff, this study emphasizes the variability that can exist when different methods of assessment are used.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22431534     DOI: 10.1309/AJCP92UCXPJMMSDU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  19 in total

Review 1.  Interphase microtubules: chief casualties in the war on cancer?

Authors:  Angela Ogden; Padmashree C G Rida; Michelle D Reid; Ritu Aneja
Journal:  Drug Discov Today       Date:  2013-11-04       Impact factor: 7.851

2.  Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

Authors:  Chad M McCall; Chanjuan Shi; Toby C Cornish; David S Klimstra; Laura H Tang; Olca Basturk; Liew Jun Mun; Trevor A Ellison; Christopher L Wolfgang; Michael A Choti; Richard D Schulick; Barish H Edil; Ralph H Hruban
Journal:  Am J Surg Pathol       Date:  2013-11       Impact factor: 6.394

3.  Clinicopathologic study of neuroendocrine tumors of gastroenteropancreatic tract: a single institutional experience.

Authors:  Megha S Uppin; Shantveer G Uppin; Chittiboyina Shiva Prasada Venkata Sunil; Monalisa Hui; Tara Roshni Paul; Nagari Bheerappa
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 4.  Systematic Review and Metaanalysis of Lymph Node Metastases of Resected Pancreatic Neuroendocrine Tumors.

Authors:  Masayuki Tanaka; Max Heckler; André L Mihaljevic; Pascal Probst; Ulla Klaiber; Ulrike Heger; Simon Schimmack; Markus W Büchler; Thilo Hackert
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

5.  Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors.

Authors:  Annika Blank; Laura Wehweck; Ilaria Marinoni; Laura Amanda Boos; Frank Bergmann; Anja Maria Schmitt; Aurel Perren
Journal:  Virchows Arch       Date:  2015-09-17       Impact factor: 4.064

6.  Ki-67 is a reliable pathological grading marker for neuroendocrine tumors.

Authors:  Ashlie Nadler; Moises Cukier; Corwyn Rowsell; Sepideh Kamali; Yael Feinberg; Simron Singh; Calvin H L Law
Journal:  Virchows Arch       Date:  2013-04-16       Impact factor: 4.064

7.  Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases.

Authors:  Gabriele Carlinfante; Paola Baccarini; Debora Berretti; Tiziana Cassetti; Maurizio Cavina; Rita Conigliaro; Alessandro De Pellegrin; Luca Di Tommaso; Carlo Fabbri; Adele Fornelli; Andrea Frasoldati; Giorgio Gardini; Luisa Losi; Livia Maccio; Raffaele Manta; Nico Pagano; Romano Sassatelli; Silvia Serra; Lorenzo Camellini
Journal:  Virchows Arch       Date:  2014-05-08       Impact factor: 4.064

8.  Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.

Authors:  Ta-Chiang Liu; Nicholas Hamilton; William Hawkins; Feng Gao; Dengfeng Cao
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

9.  The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.

Authors:  Sule Ozturk Sari; Orhun Cig Taskin; Gokcen Gundogdu; Gulcin Yegen; Semen Onder; Metin Keskin; Sezer Saglam; Yasemin Ozluk; Mine Gulluoglu; Ozgur Mete
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

10.  The ENETS/WHO grading system for neuroendocrine neoplasms of the gastroenteropancreatic system: a review of the current state, limitations and proposals for modifications.

Authors:  Marcela S Cavalcanti; Mithat Gönen; David S Klimstra
Journal:  Int J Endocr Oncol       Date:  2016-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.